Oasmia Initiates Clinical Program With Paclical® in Metastatic Breast Cancer
5/6/2013 9:18:59 AM
More...
|
Oasmia and Abbott Animal Health Sign Global Collaboration Agreement for $21.5 Million
1/9/2013 7:21:41 AM
More...
|
Oasmia and Abbott Laboratories (ABT) Sign Global Collaboration Agreement for Canine Oncology Therapies
1/7/2013 9:44:34 AM
More...
|
Oasmia Release: Positive Phase III Result From the Interim Analysis of the Study in Ovarian Cancer With Paclical(R)
8/2/2011 10:00:57 AM
More...
|
Preliminary Analysis Indicates That Oasmia's Product Candidate Paccal(R) Vet Met Primary Endpoint in Phase III Study in Dogs With Mastocytoma
5/4/2010 9:09:26 AM
More...
|
Abbott Animal Health and Oasmia Announce Exclusive Distribution Agreement for Paccal(r) Vet, a New Chemotherapeutic Agent for Dogs
7/14/2009 8:44:21 AM
More...
|
Abbott Laboratories (ABT) and Oasmia Announce Exclusive Distribution Agreement for Paccal(R) Vet, a New Chemotherapeutic Agent for Dogs
7/10/2009 7:56:32 AM
More...
|
Oasmia Says FDA Grants Paclical(r) Orphan Drug Designation for Ovarian Cancer in the US
4/14/2009 7:33:50 AM
More...
|
FDA Grants Oasmia Expedited Review Status (ERS) for Paclical(r) Vet
1/14/2009 8:44:48 AM
More...
|
Oasmia Expands License Agreement for Paclical(R) Vet to Include European-Wide Rights
6/26/2008 8:06:56 AM
More...
|